Why the study?
Does self-measurement of blood pressure at home (HBP) accurately diagnose white-coat hypertension compared to ambulatory monitoring (ABP) in untreated patients?
Does self-measurement of blood pressure at home (HBP) accurately diagnose white-coat hypertension compared to ambulatory monitoring (ABP) in untreated patients?
Answers are grounded in this paper and cite their sources.
Home blood pressure monitoring has high specificity but moderate sensitivity for detecting white-coat hypertension compared to ambulatory monitoring, supporting its use for screening.
OBJECTIVE: We examined to what extent self-measurement of blood pressure at home (HBP) can be an alternative to ambulatory monitoring (ABP) to diagnose white-coat hypertension. METHODS: In 247 untreated patients, we compared the white-coat effects obtained by HBP and ABP. The thresholds to diagnose hypertension were > or = 140/> or = 90 mmHg for conventional blood pressure (CBP) and > or = 135/> or = 85 mmHg for daytime ABP and HBP. RESULTS: Mean systolic/diastolic CBP, HBP and ABP were 155.4/100.0, 143.1/91.5 and 148.1/95.0 mmHg, respectively. The white-coat effect was 5.0/3.5 mmHg larger on HBP compared with ABP (12.3/8.6 versus 7.2/5.0 mmHg; P < 0.001). The correlation coefficients between the white-coat effects based on HBP and ABP were 0.74 systolic and 0.60 diastolic (P < 0.001). With ABP as a reference, the specificity of HBP to detect white-coat hypertension was 88.6%, and the sensitivity was 68.4%. CONCLUSION: Our findings are in line with the recommendations of the ASH Ad Hoc Panel that recommends HBP for screening while ABP has a better prognostic accuracy.
No takes yet. Share an insight, caveat, or question.
Hond et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: